The pathogenesis of chronic myeloproliferative diseases

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Chronic myeloproliferative disorders are operationally classified to include essential thrombocythemia, polycythemia vera, and agnogenic myeloid metaplasia. In most cases, clonal hematopoiesis, involving all 3 myeloid lineages, can be demonstrated. However, the underlying molecular lesions that are responsible for disease initiation and progression remain elusive. There are ongoing efforts to clarify the pathogenetic role of cytokines, bone marrow stromal cells and molecules, and intracellular aberrations in either signal transduction or apoptosis. This review discusses some of the current and past observations regard-ing the pathogenesis of chronic myeloproliferative disorders.

Original languageEnglish (US)
Pages (from-to)170-176
Number of pages7
JournalInternational Journal of Hematology
Volume73
Issue number2
StatePublished - 2001

Fingerprint

Myeloproliferative Disorders
Chronic Disease
Essential Thrombocythemia
Polycythemia Vera
Primary Myelofibrosis
Hematopoiesis
Mesenchymal Stromal Cells
Disease Progression
Signal Transduction
Apoptosis
Cytokines

Keywords

  • Agnogenic myeloid metaplasia
  • Chronic myeloproliferative disease
  • Essential thrombocythemia
  • Polycythemia vera

ASJC Scopus subject areas

  • Hematology

Cite this

The pathogenesis of chronic myeloproliferative diseases. / Tefferi, Ayalew.

In: International Journal of Hematology, Vol. 73, No. 2, 2001, p. 170-176.

Research output: Contribution to journalArticle

@article{50682ecd9a5b4118a7ebeb3d5832f6c0,
title = "The pathogenesis of chronic myeloproliferative diseases",
abstract = "Chronic myeloproliferative disorders are operationally classified to include essential thrombocythemia, polycythemia vera, and agnogenic myeloid metaplasia. In most cases, clonal hematopoiesis, involving all 3 myeloid lineages, can be demonstrated. However, the underlying molecular lesions that are responsible for disease initiation and progression remain elusive. There are ongoing efforts to clarify the pathogenetic role of cytokines, bone marrow stromal cells and molecules, and intracellular aberrations in either signal transduction or apoptosis. This review discusses some of the current and past observations regard-ing the pathogenesis of chronic myeloproliferative disorders.",
keywords = "Agnogenic myeloid metaplasia, Chronic myeloproliferative disease, Essential thrombocythemia, Polycythemia vera",
author = "Ayalew Tefferi",
year = "2001",
language = "English (US)",
volume = "73",
pages = "170--176",
journal = "International Journal of Hematology",
issn = "0925-5710",
publisher = "Springer Japan",
number = "2",

}

TY - JOUR

T1 - The pathogenesis of chronic myeloproliferative diseases

AU - Tefferi, Ayalew

PY - 2001

Y1 - 2001

N2 - Chronic myeloproliferative disorders are operationally classified to include essential thrombocythemia, polycythemia vera, and agnogenic myeloid metaplasia. In most cases, clonal hematopoiesis, involving all 3 myeloid lineages, can be demonstrated. However, the underlying molecular lesions that are responsible for disease initiation and progression remain elusive. There are ongoing efforts to clarify the pathogenetic role of cytokines, bone marrow stromal cells and molecules, and intracellular aberrations in either signal transduction or apoptosis. This review discusses some of the current and past observations regard-ing the pathogenesis of chronic myeloproliferative disorders.

AB - Chronic myeloproliferative disorders are operationally classified to include essential thrombocythemia, polycythemia vera, and agnogenic myeloid metaplasia. In most cases, clonal hematopoiesis, involving all 3 myeloid lineages, can be demonstrated. However, the underlying molecular lesions that are responsible for disease initiation and progression remain elusive. There are ongoing efforts to clarify the pathogenetic role of cytokines, bone marrow stromal cells and molecules, and intracellular aberrations in either signal transduction or apoptosis. This review discusses some of the current and past observations regard-ing the pathogenesis of chronic myeloproliferative disorders.

KW - Agnogenic myeloid metaplasia

KW - Chronic myeloproliferative disease

KW - Essential thrombocythemia

KW - Polycythemia vera

UR - http://www.scopus.com/inward/record.url?scp=0035258037&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035258037&partnerID=8YFLogxK

M3 - Article

C2 - 11372728

AN - SCOPUS:0035258037

VL - 73

SP - 170

EP - 176

JO - International Journal of Hematology

JF - International Journal of Hematology

SN - 0925-5710

IS - 2

ER -